Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Ecometics, Inc.
WARNING LETTER
•Ecometics, Inc.•September 7, 2018

Ecometics, Inc. – FDA Warning Letter, Sep 7, 2018

Record Details

The FDA inspected Ecometics, Inc., a drug manufacturing facility in Norwalk, CT, from August 17 to September 7, 2018, revealing significant violations of current Good Manufacturing Practice (CGMP) regulations (21 CFR parts 210 and 211). The firm's drug products are considered adulterated and misbranded. Key CGMP deficiencies include inadequate cleaning procedures for equipment shared between drug and non-drug products (21 CFR 211.67(b)), failure to conduct appropriate microbiological testing for drug products (21 CFR 211.165(b)), an unvalidated water system (21 CFR 211.63), and an inadequate stability testing program with non-stability-indicating methods and missed intervals (21 CFR 211.166(a)). The stability issue was a repeat observation from a 2016 inspection, indicating inadequate executive management oversight. Additionally, Ecometics failed to fulfill its drug registration and listing obligations under section 510 of the FD&C Act, leading to misbranded drugs (sections 502(o), 502(a), 502(f)(2)). The firm was also distributing unapproved prescription drugs. Ecometics' responses were deemed inadequate. The FDA requires immediate corrective actions, including discontinuing shared equipment for drugs, providing detailed testing specifications, validating the water system, and implementing a comprehensive stability program CAPA. A CGMP consultant is strongly recommended. Failure to promptly correct these systemic issues may result in legal action, including seizure and injunction, and impact future approvals or export certificates. A written response within 15 working days is required.

Company
Ecometics, Inc.
Inspection date
September 7, 2018
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations I
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · 40ef96e6-793e-4a58-ae25-700cb55cb090

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 U.S.C. 331(a)21 CFR 21021 CFR 21121 U.S.C. 36021 U.S.C. 331(p)21 U.S.C. 352(o)21 U.S.C. 352(a)21 U.S.C. 352(f)(2)21 CFR 211.67(b)

Full citation text and observation details available on the Dashboard.

Other documents for Ecometics, Inc.
  • 483 - 2023-02-06February 6, 2023
  • 483 - 2021-09-10September 10, 2021
  • 483 - 2018-09-07September 7, 2018
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ecometics, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.